im basing this on the fundamentals, isonep which they call LT1009 is not only going to work but if you look at the crystal stucture it will completely neutralize the S1P lipid. and the same goes for asonep. and dont forget about lpathomab either it absorbs the LPA which promotes severe pain in neropathy and TBI and spinal injury. to put it simply pfizer is already running this biotech just listen to pancoast interview back in january of this year. im really not into technicals with this stock but i will tell you this has blockbuster potential with isonep and asonep and dont think gfor a second that roche will turn this into a bidding war with pfizer
We've got a golden cross going, although the last time we had one, it sunk in less than a month. If we stay at these levels for 1 more month, I'll start adding more. The Fed easing is being used by manipulators tho.
Bigfella, I hope you dumped CCXI before the trial result. I dumped too soon at 12,I think. Bakers never a sure bet, but I'm learning it often is better to buy after a stock sells off on great trial results, or FDA decisions.